Company page
Keymed Biosciences, Inc.
Keymed Biosciences, Inc. is a public company listed on the Hong Kong Stock Exchange under the ticker 2162. The company has a market capitalization of approximately HKD 2.06 billion. Keymed focuses on the development of innovative therapies in the biomedical field.
- Ticker
- 2162:HKEX
- Asset type
- Stock
- Market cap
- $2.06B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- HKEX
- Currency
- HKD